Nationwide Overdose Crisis Spurs Federal Funding For New Opioid Reversal Treatment
Portfolio Pulse from Nina Zdinjak
Indivior PLC has received its first order for the OPVEE nasal spray from the Biomedical Advanced Research and Development Authority (BARDA) to address fentanyl overdoses. This order, funded by Project BioShield, aims to enhance emergency response capabilities in the U.S. against synthetic opioid overdoses.
August 27, 2024 | 1:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Indivior PLC's OPVEE nasal spray has been ordered by BARDA to address fentanyl overdoses, marking a significant step in emergency response preparedness. This order could boost Indivior's market presence and revenue.
The order from BARDA for OPVEE nasal spray is a significant endorsement of Indivior's product, potentially increasing its market presence and revenue. The use of federal funds and the potential for annual purchases over nine years further solidifies its importance.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100